Lyfebulb – CVS Kidney Care® Innovation Challenge: Accelerating Innovations in Kidney Disease to Improve Health Equity and Outcomes

Austin, TX
May 18-19, 2022

CHALLENGE TIMELINE

November 1, 2021
Applications Open
December 14, 2021
Submission Deadline
March 2022
Finalist Announcement
May 18-19, 2022
Innovation Challenge
May 19, 2022
Winner Announcement

ABOUT THE SUMMIT AND AWARD

The Lyfebulb-CVS Kidney Care® Innovation Challenge will take place in May 2022 and was accepting applications through December 14, 2021. Select applicants received an invitation to pitch their ideas and solutions to an expert panel of judges comprised of healthcare industry, medical, and patient leaders over the course of the two-day summit. One entrepreneur will be awarded the 2022 Lyfebulb-CVS Kidney Care Innovation Award, including a $25,000 monetary grant to grow their company. Competing finalists may be considered by CVS Kidney Care for possible partnerships or investment opportunities.

In addition to presenting their innovative ventures, finalists will have the opportunity to exchange ideas on how to further advance patient innovation in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) and engage with Lyfebulb founders, CVS Kidney Care leadership, representatives from the CKD/ESKD patient community, key opinion leaders, and potential investors.

Note: The Summit is currently scheduled to take place in person. However, Lyfebulb will continue to monitor the national, state, and local COVID-19 situation, and the details of this event remain subject to change from in-person to virtual as needed.

SHARE

KEY PILLARS OF INNOVATION

Through Lyfebulb and CVS Kidney Care’s shared commitment to patients and their loved ones, the Lyfebulb-CVS Kidney Care Innovation Challenge is seeking a wide range of solutions to address health disparities among patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). In order to address the health disparities facing kidney patients and their care partners, we will identify scalable solutions that do one or more of the following:

    • Improve early evaluation for kidney disease
    • Educate health care providers and patients around eGFR kidney function
    • Increase cultural empathy among healthcare workers
    • Remove social barriers that affect kidney health outcomes
    • Increase the diversity of nephrologists

We also encourage the submission of all creative and strategic solutions to provide equitable care and improve patient and care partner outcomes. Primary areas of interest supporting this mission include education and awareness, early identification and disease progression, and overall quality of life.

SHARE

FINALISTS

JUDGES

Keisha L. Gibson, MD, MPH, FASN

Associate Professor of Medicine and Pediatrics, Department of Medicine Vice Chair of Diversity and Inclusion, and Chief, Pediatric Nephrology Division at UNC School of Medicine

Kevin Longino

CEO of National Kidney Foundation

Glenda Roberts

Director, External Relations and Patient Engagement at UW Kidney Research Institute/Center for Dialysis Innovation and Chief Strategy and Operations Officer – Justice, Equity, Diversity and Inclusion Center

Jeiran Otmishi

Co-Founder of Rumi Edge

Jennifer Miller

Executive Director, Commercialization for CVS Kidney Care®

JUDGING CRITERIA

The judging panel will assess the following:

UNMET NEED

    • Strategic basis for addressing health equity challenges facing patients and their care partners
    • How these challenges are specifically being addressed

IMPACT

    • Potential of the innovation to improve the lives of people affected by kidney disease
    • Degree of impact (market impact and patient impact)
    • Measurability of impact

MARKET FEASIBILITY

    • Uniqueness to the market
    • Feasibility of development and implementation
    • Market sustainability

THE CHALLENGE IN NUMBERS

2

Days

The Challenge will take place May 18-19, 2022

10

Finalists

Entrepreneurs will pitch their ideas and solutions over the 2 days

5

Judges

An expert panel of judges comprised of healthcare industry, medical, and patient leaders will assess the finalists

$25

Thousand

One entrepreneur will be awarded the 2022 Lyfebulb-CVS Health Innovation Award, including a $25,000 monetary grant to grow their company